No Data
No Data
Pharmaron (300759.SZ): Shareholder Xin Longcheng intends to reduce its shareholding by no more than 0.90%.
Kanglong Huicheng (300759.SZ) announced on October 15 that shareholder Xinlongcheng plans to reduce its shareholding by no more than 16,000,074 shares (0.90% of the total share capital after deducting the repurchased shares) through centralized bidding or block trading on the Shenzhen Stock Exchange within 3 months after 15 trading days from the date of this announcement until November 6, 2024.
Pharmaron (03759.HK) plans to hold a board of directors meeting on October 29 to approve the third-quarter performance.
Kanglong Huicheng (03759.HK) announced on October 15 that the board of directors will hold a meeting on October 29, 2024 (Tuesday) to review and approve the third quarter performance of the company and its subsidiaries for the nine months ending September 30, 2024.
PHARMARON: NOTICE OF BOARD MEETING
Trending Industry Today: TIGERMED Leads Losses In CRO Stocks
[Brokerage Focus] China Post Securities expects the pharmaceutical sector to continue to rise uniformly, suggesting prioritizing the layout of various segmented sectors and leading companies in the first and second tiers during the general rise phase.
Golden Herald Financial News | China Post Securities stated that since the end of September, the pharmaceutical sector has been boosted by the national comprehensive incremental policy, solidly promoting the economy towards a higher-quality structure under the heavy bullish push, leading to a rapid rebound of the index by about 29%, reversing the continuous decline of nearly 4 years. Looking at the current PE (TTM), A-share pharmaceuticals are at 32 times, and Hong Kong stocks at 23 times. The previous continuous decline has already deviated from the fundamentals. The bank believes that the increase in market risk appetite will accelerate the sector's valuation repair. As of H1 2024, the institutions hold a 7.3% stake in the CSI SWS Health Care Index sector, which, although slightly lower than the end of 2023, still remains at a historically high level, indicating a general positive sentiment among institutions.
Trending Industry Today: JOINN Leads Gains In CRO Stocks